NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Sanders GD, Powers B, Crowley M, et al. Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease: Identification of Future Research Needs from Comparative Effectiveness Review No. 18 [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Nov. (Future Research Needs Papers, No. 8.)
Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease: Identification of Future Research Needs from Comparative Effectiveness Review No. 18 [Internet].
Show details- ACE
Angiotensin-converting enzyme
- ACEI(s)
Angiotensin-converting enzyme inhibitor(s) [used in tables only]
- AHRQ
Agency for Healthcare Research and Quality
- ARB(s)
Angiotensin II receptor blocker(s)/antagonist(s)
- CER
Comparative Effectiveness Review
- CHF
Congestive heart failure
- CPT
Current Procedural Terminology
- CVA
Cerebrovascular accident
- EPC
Evidence-based Practice Centers
- ICD-9
International Classification of Diseases, Ninth Revision
- IHD
Ischemic heart disease
- ITT
Intention-to-treat
- LV
Left ventricular
- LVEF
Left ventricular ejection fraction
- MI
Myocardial infarction
- PICO
Population, interventions, comparators of interest, and outcomes
- PICOTS
Population, interventions, comparators of interest, outcomes, timing, and settings
- QOL
Quality of life
- RCT
Randomized controlled trial
- Abbreviations - Future Research Needs for Angiotensin Converting Enzyme Inhibito...Abbreviations - Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
Your browsing activity is empty.
Activity recording is turned off.
See more...